{"id":165716,"date":"2024-11-19T07:59:58","date_gmt":"2024-11-19T12:59:58","guid":{"rendered":"https:\/\/44.250.171.167\/?p=165716"},"modified":"2024-11-19T07:59:58","modified_gmt":"2024-11-19T12:59:58","slug":"mankind-pharma-ltd-q2fy25-34-rise-in-profits","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/mankind-pharma-ltd-q2fy25-34-rise-in-profits\/","title":{"rendered":"Mankind Pharma Ltd Q2FY25; 34% rise in Profits"},"content":{"rendered":"<p>Incorporated in 1995, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations in various acute and chronic therapeutic areas and several consumer healthcare products.<\/p>\n<h2>\nFinancial Results:<\/h2>\n<p>Mankind Pharma Ltd reported Revenues for Q2FY25 of \u20b92,530.00 Crores up from \u20b92,260.00 Crore year on year, a rise of 11.95%.<\/p>\n<p>Total Expenses for Q2FY25 of \u20b91,865.00 Crores up from \u20b91,743.00 Crores year on year, a rise of 7.0%.<\/p>\n<p>Consolidated Net Profit of \u20b9634.00 Crores up 34.04% from \u20b9473.00 Crores in the same quarter of the previous year.<\/p>\n<p>The Earnings per Share is \u20b915.84, up 34.24% from \u20b911.80 in the same quarter of the previous year.<\/p>\n<p>&nbsp;<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-large wp-image-165717\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/download-15-839x1024.png\" alt=\"\" width=\"640\" height=\"781\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/download-15-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/download-15-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/download-15-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/download-15-1259x1536.png 1259w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/download-15.png 1489w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><\/p>\n<p>*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.<\/p>\n<p>*The presented data is automatically generated. It may occasionally generate incorrect information.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Incorporated in 1995, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations in various acute and chronic therapeutic areas and several consumer healthcare products. Financial Results: Mankind Pharma Ltd reported Revenues for Q2FY25 of \u20b92,530.00 Crores up from \u20b92,260.00 Crore year on year, a rise of 11.95%. Total Expenses for Q2FY25 of \u20b91,865.00 Crores up [&hellip;]<\/p>\n","protected":false},"author":1863,"featured_media":165717,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392,5747],"tags":[],"class_list":["post-165716","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","category-healthcare-stocks"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/download-15.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":165862,"url":"https:\/\/alphastreet.com\/india\/aurobindo-pharma-ltd-q2fy25-9-rise-in-profits\/","url_meta":{"origin":165716,"position":0},"title":"Aurobindo Pharma Ltd Q2FY25; 9% rise in Profits","author":"Divyansh_Kasana","date":"December 2, 2024","format":false,"excerpt":"Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.(Source : 202003 Annual Report Page No:159) Financial Results: Aurobindo Pharma Ltd reported Revenues for Q2FY25 of \u20b97,796.00 Crores up from \u20b97,219.00 Crore year on year, a rise of 7.99%. Total Expenses for\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/BK.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/BK.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/BK.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/BK.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/BK.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/BK.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":165443,"url":"https:\/\/alphastreet.com\/india\/ajanta-pharma-ltd-q2fy25-11-rise-in-profits\/","url_meta":{"origin":165716,"position":1},"title":"Ajanta Pharma Ltd Q2FY25; 11% rise in Profits","author":"Divyansh_Kasana","date":"November 7, 2024","format":false,"excerpt":"Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70). Financial Results: Ajanta Pharma Ltd reported Revenues for Q2FY25 of \u20b91,187.00 Crores up from \u20b91,028.00 Crore year on year, a rise of 15.47%. Total Expenses for Q2FY25 of\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/LE.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/LE.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/LE.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/LE.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/LE.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/LE.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":165856,"url":"https:\/\/alphastreet.com\/india\/asian-paints-ltd-q2fy25-44-fall-in-profits-3\/","url_meta":{"origin":165716,"position":2},"title":"Asian Paints Ltd Q2FY25; 44% fall in Profits","author":"Divyansh_Kasana","date":"December 2, 2024","format":false,"excerpt":"AstraZeneca Pharma India Ltd is engaged in the business of manufacture, distribution and marketing of pharmaceutical products. Financial Results: Astrazeneca Pharma India Ltd reported Revenues for Q2FY25 of \u20b98,028.00 Crores down from \u20b98,479.00 Crore year on year, a fall of 5.32%. Total Expenses for Q2FY25 of \u20b97,093.00 Crores up from\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/HJ.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/HJ.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/HJ.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/HJ.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/HJ.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/HJ.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":165787,"url":"https:\/\/alphastreet.com\/india\/natco-pharma-ltd-q2fy25-83-rise-in-profits\/","url_meta":{"origin":165716,"position":3},"title":"Natco Pharma Ltd Q2FY25; 83% rise in Profits","author":"Chirag Gupta","date":"November 21, 2024","format":false,"excerpt":"NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged in developing, manufacturing, and marketing complex products for niche therapeutic areas. NATCO has established its presence in all three business segments viz. finished dosage formulations (\u201cFDF\u201d), active pharmaceutical ingredients (\u201cAPIs\u201d), Contract Manufacturing Business. Financial Results:\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/download-13-1.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/download-13-1.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/download-13-1.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/download-13-1.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/download-13-1.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/download-13-1.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":165295,"url":"https:\/\/alphastreet.com\/india\/piramal-pharma-ltd-q2fy25-360-rise-in-profits\/","url_meta":{"origin":165716,"position":4},"title":"Piramal Pharma Ltd Q2FY25; 360% rise in Profits","author":"Chirag Gupta","date":"October 29, 2024","format":false,"excerpt":"Piramal Pharma Limited (PPL) is part of the Piramal group of companies. The company operates through 3 major segments (1) Contract development and manufacturing organisations (CDMO), (2) Complex hospital generics (critical care), and (3) consumer healthcare (OTC). Company entered Pharma space back in 1988 with acquisition of Nicholas Laboratories and\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/download-2-1.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/download-2-1.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/download-2-1.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/download-2-1.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/download-2-1.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/download-2-1.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":165888,"url":"https:\/\/alphastreet.com\/india\/balaji-amines-ltd-q2fy25-14-rise-in-profits\/","url_meta":{"origin":165716,"position":5},"title":"Balaji Amines Ltd Q2FY25; 14% rise in Profits","author":"Divyansh_Kasana","date":"December 3, 2024","format":false,"excerpt":"Balaji Amines Ltd specialises in manufacturing Methylamines, Ethylamines, Derivatives of specialty chemicals and Pharma Excipients. These have been the main products, it also have facilities for the manufacturing of derivatives, which are down-stream products for various pharma\/pesticide industries apart from user specific requirements. It is one of the largest manufacturers\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/BALAJI.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/BALAJI.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/BALAJI.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/BALAJI.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/BALAJI.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/BALAJI.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/165716","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1863"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=165716"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/165716\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/165717"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=165716"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=165716"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=165716"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}